Key Partnerships

UCP is proud to partner with companies that stand as a model of aligning corporate philanthropy with the needs of the real people they serve. With their support, we are able provide vital resources that can improve the lives of children and adults living with chronic diseases and disabilities.

The Hershey Company is dedicated to making a difference in the communities where we live, work and do business, with a particular focus on children at risk. UCP is grateful for Hershey's longtime support of My Child Without Limits.

MetLife® Center for Special Needs Planning is dedicated to helping families secure both lifetime care and quality of life for their dependents with special needs. As a partner in UCP’s Public Education & Outreach programs, through presentations to our affiliates at national and regional meetings, and in educating our families about the need to plan for the future, MetLife® exemplifies the best of our mission to help people with disabilities lead a life without limits.

Medtronic, Inc. is the world's leading medical technology company, alleviating pain, restoring health and extending life for people with chronic disease. Programs like PatientLink help build awareness, educate and advocate on behalf of our patients and their families. UCP is grateful for Medtronic and the Medtronic Foundation's support of My Child Without Limits and BraveKids.

Our Newest Partner

UCP welcomes Cord Blood Registry (CBR) as a new partner for the My Child Without Limits Parent/Caregiver Welcome Packs. Like UCP, CBR believes that all children deserve to live a life without limits and understand the importance of sharing valuable information, hope and a new community to all those who visit My Child Without Limits.

CBR was founded on the belief that saving newborn cord blood stem cells can change the future of medicine. For more than 15 years, CBR has led the industry in technical innovations and are entrusted by parents with storing cord blood and tissue for more than 400,000 children. CBR created the Center for Regenerative Medicine to fuel innovation in newborn stem cell medicine through research grants, clinical trials, and information sharing.

CBR is currently partnering with leading medical institutions that are exploring the use of a newborn’s own stem cells to help heal injuries or treat conditions. CBR is the exclusive research partner for three ongoing FDA-regulated clinical trials evaluating the use of a child’s own (autologous) cord blood stem cells for the treatment of:

• Hearing Loss: Children’s Memorial Hermann Hosphersey logoital in Houston, Texas

• Traumatic Brain Injury: The University of Texas Health Science Center in Houston (UTHealth)

• Cerebral Palsy: Georgia Health Sciences University

To learn more about Cord Blood Registry, please visit www.cordblood.com